Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 12, 2023
Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular DiagnosticsSamuel J Modlin, Mikael Mansjö, Jim Werngren, et al.Antimicrobial Agents and Chemotherapy|March 4, 2020
Systematic Review of Whole-Genome Sequencing Data To Predict Phenotypic Drug Resistance and Susceptibility in Swedish Mycobacterium tuberculosis Isolates, 2016 to 2018Theresa Enkirch, Jim Werngren, Ramona Groenheit, et al.Antimicrobial Agents and Chemotherapy|June 15, 2016
Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in ChinaDange Li, Yi Hu, Jim Werngren, et al.BMC Infectious Diseases|July 12, 2014
Evaluation of a microcolony growth monitoring method for the rapid determination of ethambutol resistance in Mycobacterium tuberculosisAlice L den Hertog, Sandra Menting, Ernst T Smienk, et al.Antimicrobial Agents and Chemotherapy|June 2, 2016
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in ChinaXubin Zheng, Rongrong Zheng, Yi Hu, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 16, 2021
Additional drug resistance for Mycobacterium tuberculosis during turnaround time for drug-susceptibility testing in China: A multicenter observational cohort studyJiahui Zhu, Ziwei Bao, Yan Xie, et al.Antimicrobial Agents and Chemotherapy|November 1, 2017
Detection of Mycobacterium tuberculosis pncA Mutations by the Nipro Genoscholar PZA-TB II Assay Compared to Conventional SequencingMelisa J Willby, Maria Wijkander, Joshua Havumaki, et al.Journal of Clinical Microbiology|March 1, 2013
Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?Dorte Bek Folkvardsen, Erik Svensson, Vibeke Ø Thomsen, et al.The Journal of Antimicrobial Chemotherapy|July 28, 2009
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosisThomas Schön, Pontus Juréen, Christian G Giske, et al.Fitoterapia|April 5, 2011
Ethyl p-methoxycinnamate isolated from a traditional anti-tuberculosis medicinal herb inhibits drug resistant strains of Mycobacterium tuberculosis in vitroDivya Lakshmanan, Jim Werngren, Leny Jose, et al.Pageof 6